One-carbon therapeutics AB logo

One-carbon therapeutics AB jobs and careers

Sweden

About One-carbon therapeutics AB

One-carbon therapeutics AB is developing first-in-class MTHFD1/2 inhibitors of one-carbon metabolism, representing a novel way of attacking the DNA damage response (DDR) and targeting cancer.

Founded
2020
Employees
1 to 10
Headquarters
Sweden

Leadership

The top of One-carbon therapeutics AB's org chart, with how many people report into each leader.

AS

Ana Slipicevic

Chief Executive Officer